BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36919880)

  • 1. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.
    Miranda J; Pinto PVA; Kinochita F; Garcia CM; El Homsi M; Vilela de Oliveira C; Pandini RV; Nahas CSR; Nahas SC; Gollub MJ; Horvat N
    AJR Am J Roentgenol; 2023 Aug; 221(2):206-216. PubMed ID: 36919880
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
    Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis.
    McCawley N; Clancy C; O'Neill BD; Deasy J; McNamara DA; Burke JP
    Dis Colon Rectum; 2016 Dec; 59(12):1200-1208. PubMed ID: 27824706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/MRI Characterization of Mucinous Versus Nonmucinous Components of Rectal Adenocarcinoma: A Comparison of Tumor Metabolism and Cellularity.
    Queiroz MA; Naves A; Dreyer PR; Cerri GG; Buchpiguel CA
    AJR Am J Roentgenol; 2021 Feb; 216(2):376-383. PubMed ID: 33295813
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging of mucin pools in locally advanced rectal mucinous adenocarcinoma predicts tumor response to neoadjuvant therapy.
    Cao W; Li B; Gong J; Hu M; Li W; Pan X; Zhou Z
    Eur J Radiol; 2020 Apr; 125():108890. PubMed ID: 32092684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
    Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
    Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous rectal cancer: concepts and imaging challenges.
    Horvat N; Hope TA; Pickhardt PJ; Petkovska I
    Abdom Radiol (NY); 2019 Nov; 44(11):3569-3580. PubMed ID: 30993392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
    Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
    Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
    Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
    Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery.
    Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
    Tumori; 2016; 102(1):114-21. PubMed ID: 26450451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
    Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
    Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression.
    Duggan WP; Kisakol B; O'Connell E; Matveeva A; O'Grady T; McDonough E; Lindner AU; McNamara D; Longley D; Ginty F; Burke JP; Prehn JHM
    Dis Colon Rectum; 2023 Jul; 66(7):914-922. PubMed ID: 36525395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced MRI for T Restaging of Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy and Radiation Therapy.
    Lu QY; Guan Z; Zhang XY; Li XT; Sun RJ; Li QY; Sun YS
    Radiology; 2022 Nov; 305(2):364-372. PubMed ID: 35852424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
    Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
    Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucin Pools Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Marker of Response or Epiphenomenon?
    Reynolds IS; O'Connell E; Fichtner M; Kay EW; McNamara DA; Prehn JHM; Burke JP
    Am J Surg Pathol; 2020 Feb; 44(2):280-287. PubMed ID: 31567193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.